ALX ONCOLOGY HOLDINGS INC·4

Mar 23, 4:05 PM ET

Pinto Shelly 4

Research Summary

AI-generated summary

Updated

ALX Oncology SVP Shelly Pinto Sells 903 Shares

What Happened
Shelly Pinto, SVP, Finance and CAO of ALX Oncology Holdings Inc. (ALXO), sold 903 shares on 2026-03-19 at $2.17 per share, for total proceeds of $1,960. The filing indicates the shares were sold to satisfy tax withholding obligations related to the vesting of performance-based restricted stock units — a routine, non-directional transaction.

Key Details

  • Transaction date: 2026-03-19; Price: $2.17 per share; Shares sold: 903; Proceeds: $1,960.
  • Transaction type: Sale (S) — open market or private sale.
  • Footnote: Sale was to satisfy tax obligations in connection with vesting of performance-based RSUs.
  • Shares owned after transaction: Not disclosed in this Form 4.
  • Filing date: 2026-03-23 — filing appears timely (within the usual 2 business-day window).

Context
Tax-withholding sales after RSU vesting are common and generally reflect routine obligations rather than an insider expressing a bearish view. For retail investors, outright purchases are typically more informative about insider sentiment; this transaction should be viewed as administrative in nature.